Pharmaceutical manufacturer for Alginate

The IMCD Group stands as a dominant force worldwide in the marketing, sales, and distribution of specialized chemicals and components. Its outcome-oriented experts offer tailored solutions to suppliers and clients throughout EMEA, Americas, and Asia-Pacific, delivering extensive product portfolios encompassing household, industrial and institutional maintenance, personal care, food and nutrition, pharmaceuticals, lubricants and energy, coatings and construction, advanced materials, and synthesis. In 2020, the IMCD Group achieved revenues of EUR 2,775 million, employing almost 3,300 individuals across more than 50 nations. IMCD's committed team of technical and business professionals collaborates closely to customize top-notch solutions and deliver expertise-based value to approximately 50,000 clients and a varied set of leading suppliers. IMCD shares can be traded on Euronext, Amsterdam (IMCD).

Qingdao Bright Moon Seaweed Group Co Ltd is a private group focused on advanced technology, specializing in the comprehensive processing of seaweed and the production of sugar alcohol. Founded in 1968, it is among the earliest companies in China to process seaweed

At the Pharma Solutions division of IFF, we leverage unparalleled knowledge and technical expertise along with top-notch ingredients to assist you in all aspects of developing products in the dietary supplement sector. Whether you require